Latest news with #transdermal
Globe and Mail
a day ago
- Business
- Globe and Mail
Nutriband (NASDAQ: NTRB) to Present at Emerging Growth Conference on August 20
Nutriband (NASDAQ: NTRB) announced it will participate in the Emerging Growth Conference on August 20, 2025. Chairman Serguei Melnik will deliver a live, interactive presentation and may open the floor for real-time questions from shareholders and the investment community. To view the full article, visit About Nutriband Inc. We are primarily engaged in the development of a portfolio of transdermal pharmaceutical products. Our lead product under development is an abuse-deterrent fentanyl patch incorporating our AVERSA(TM) abuse-deterrent technology. AVERSA(TM) technology can be incorporated into any transdermal patch to prevent the abuse, misuse, diversion, and accidental exposure of drugs with abuse potential. About BioMedWire BioMedWire ('BMW') is a specialized communications platform with a focus on the latest developments in the Biotechnology (BioTech), Biomedical Sciences (BioMed) and Life Sciences sectors. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today's market, BMW brings its clients unparalleled recognition and brand awareness. BMW is where breaking news, insightful content and actionable information converge. To receive SMS alerts from BioMedWire, 'Biotech' to 888-902-4192 (U.S. Mobile Phones Only) For more information, please visit Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: BioMedWire Austin, Texas 512.354.7000 Office Editor@ BioMedWire is powered by IBN
Associated Press
21-07-2025
- Health
- Associated Press
No More Pills, No More Struggles: Korean Innovation Transforms How Kids Approach Growth Support
HAUTUKI GROWTH SUPPORT PATCH Korean patch Hautuki ends supplement battles. Kids manage growth support independently through bedtime application. Unlike oral supplements 60% resist, transdermal system delivers nutrients through skin over 8-10 hours. Emma Chen, 9, went from hiding at vitamin time to proudly applying patches. 'Now it's drama-free,' says Hong Kong mother. HONG KONG - Every evening at 8 PM, 9-year-old Emma Chen used to hide in her bedroom, dreading the nightly battle with her mother over growth vitamins. The familiar scene played out in households across Asia: tears, negotiations, and ultimately, a frustrated parent watching their child reluctantly swallow yet another pill. Today, Emma looks forward to bedtime. She proudly applies a small patch near her arm – a routine she now manages entirely on her own. 'I don't have to taste anything yucky anymore,' she explains, while her mother watches with visible relief. Emma's transformation represents a growing trend among families discovering Hautuki, a Korean-developed patch-based growth support system that's quietly revolutionizing how children approach their health routines. Nine-year-old Emma applies her Hautuki patch independently before bedtime - a routine she now manages entirely on her own. The Daily Battle Millions of Parents Know Too Well For parents concerned about their child's growth, the statistics paint a challenging picture. Industry research suggests that up to 60% of children regularly resist taking oral supplements, creating a cycle of stress that often defeats the purpose of growth support entirely. 'We were spending more energy fighting about vitamins than actually helping our child grow,' says Jennifer Wong, a Hong Kong mother of two. Online parent forums are filled with similar stories: children who gag at the sight of pills, families who've tried every flavored vitamin on the market, and parents who eventually give up on supplementation altogether. When Kids Take Control The breakthrough came when Custics Corporation, a Seoul-based biotechnology company, asked a different question: instead of making supplements easier for parents to give, what if children could manage their growth routine independently? Their answer was Hautuki – a transdermal patch that delivers nutrients through the skin, eliminating the need for swallowing, tasting, or parental intervention. 'When children feel ownership over their health choices, compliance becomes natural rather than forced,' explains Dr. Sarah Kim, a pediatric nutritionist who has observed the product's impact. The technology works through controlled absorption via the skin, bypassing the digestive system entirely. Children simply apply one patch before bedtime – a process most can master independently within days. The Science of Consistency Traditional oral supplements face what researchers call the 'compliance gap' – the difference between prescribed and actual intake. Even motivated families struggle to maintain perfect supplement routines, with missed doses occurring an average of 2-3 times per week. Hautuki's transdermal delivery system provides steady nutrient absorption over 8-10 hours, creating more consistent blood levels than traditional oral supplements that create peaks and valleys in nutrient availability. 'The patch doesn't just solve the compliance problem,' notes Dr. Michael Chang, a Hong Kong pediatrician. 'It actually provides more stable nutrient delivery than oral supplements, even when those are taken perfectly.' A Regional Success Story Since launching in South Korea, Hautuki has expanded across major Asian markets, with Hong Kong representing one of its fastest-growing segments. Local distributors report that word-of-mouth referrals drive much of the product's growth. 'Asian parents have always been proactive about their children's growth, but they're increasingly looking for solutions that reduce family stress while maintaining effectiveness,' says wellness industry analyst Lisa Park. " Hautuki hits both targets.' Changing the Conversation Perhaps most significantly, Hautuki is changing how families talk about growth support. Instead of viewing supplementation as something imposed by parents, children increasingly see it as a personal routine they can manage independently. 'My daughter actually reminds me when it's time to reorder patches,' laughs Maria Santos, a Hong Kong expatriate mother. 'She's taken complete ownership of her growth routine.' Child psychologists note that when children successfully manage health routines on their own, it builds confidence and establishes positive patterns for lifelong self-care. The Future of Family Health As Hautuki continues its expansion across Asia, industry observers are watching whether its success signals broader changes in pediatric health products. The emphasis on child autonomy and stress reduction represents a departure from traditional approaches. 'We're seeing the emergence of 'child-centric' health products,' explains healthcare innovation researcher Dr. James Liu. 'Companies are asking how to make children more effective at managing their own health.' For families like the Chens, the change has been transformative. Emma now views her nightly patch application as a sign of growing up, not a medical chore. 'Growth support used to be about pills, schedules, and arguments,' reflects Jennifer Wong. 'Now it's just part of life – simple, effective, and completely drama-free.' As more families discover patch-based solutions, the days of supplement struggles may soon become a thing of the past, replaced by a new generation of children who approach their health with confidence and independence. Media Contact Company Name: Glovertise Contact Person: Erick Email: Send Email Phone: 01091916367 Address:7/F TOWER 2 SOUTH SEAS CTR 75 MODY RD #706 City: HONG KONG State: TSIM SHA TSUI Country: HongKong Website: Press Release Distributed by To view the original version on ABNewswire visit: No More Pills, No More Struggles: Korean Innovation Transforms How Kids Approach Growth Support
Yahoo
02-07-2025
- Business
- Yahoo
Nutriband Announces 25% Preferred Stock Dividend as it targets filing for FDA approval
ORLANDO, Fla., July 02, 2025 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ:NTRB) (NASDAQ:NTRBW) ('Nutriband' or the 'Company') announced today that its Board of Directors has approved and declared a 25% preferred stock dividend. Shareholders of record on July 25th 2025 will receive one preferred share for every four shares of common stock held. The pay date for shareholders to receive their new issuance will be August 5th. Each preferred share will be convertible to one share of common stock following FDA approval of the Company's AVERSA Fentanyl product. If the preferred share remains unconverted it shall be entitled to a cash dividend paid from the profits of the company on an annual basis as decided by the board of Directors. "Our core goal is to continue to create value for our shareholders particularly as we near closer to the commercialization of AVERSA fentanyl. We recently highlighted our Commercialization manufacturing process scale up with Kindeva and we are now laser focused on finalizing our development pathway to FDA approval," said Gareth Sheridan, CEO. About AVERSA™ Abuse-Deterrent Transdermal Technology Nutriband's AVERSA™ abuse-deterrent transdermal technology incorporates aversive agents into transdermal patches to prevent the abuse, diversion, misuse, and accidental exposure of drugs with abuse potential. The AVERSA™ abuse-deterrent technology has the potential to improve the safety profile of transdermal drugs susceptible to abuse, such as fentanyl, while making sure that these drugs remain accessible to those patients who really need them. The technology is covered by a broad intellectual property portfolio with patents granted in the United States, Europe, Japan, Korea, Russia, China, Canada, Mexico, and Australia. About Nutriband Inc. We are primarily engaged in the development of a portfolio of transdermal pharmaceutical products. Our lead product under development is an abuse-deterrent fentanyl patch incorporating our AVERSA™ abuse-deterrent technology. AVERSA™ technology can be incorporated into any transdermal patch to prevent the abuse, misuse, diversion, and accidental exposure of drugs with abuse potential. The Company's website is Any material contained in or derived from the Company's websites or any other website is not part of this press release. Forward-Looking Statements Certain statements contained in this press release, including, without limitation, statements containing the words ''believes," "anticipates," "expects" and words of similar import, constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve both known and unknown risks and uncertainties. The Company's actual results may differ materially from those anticipated in its forward-looking statements as a result of a number of factors, including those including the Company's ability to develop its proposed abuse-deterrent fentanyl transdermal system and other proposed products, its ability to obtain patent protection for its abuse technology, its ability to obtain the necessary financing to develop products and conduct the necessary clinical testing, its ability to obtain Federal Food and Drug Administration approval to market any product it may develop in the United States and to obtain any other regulatory approval necessary to market any product in other countries, including countries in Europe, its ability to market any product it may develop, its ability to create, sustain, manage or forecast its growth; its ability to attract and retain key personnel; changes in the Company's business strategy or development plans; competition; business disruptions; adverse publicity and international, national and local general economic and market conditions and risks generally associated with an undercapitalized developing company, as well as the risks contained under "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" in the Company's Form S-1, Forms 10-K's and Forms 10-Q's, and the Company's other filings with the Securities and Exchange Commission. Except as required by applicable law, we undertake no obligation to revise or update any forward-looking statements to reflect any event or circumstance that may arise after the date hereof. Contact Information: Nutriband Inc. Phone: 407-377-6695 Email: info@ SOURCE: Nutriband Inc.
Daily Mail
17-06-2025
- Health
- Daily Mail
Are YOU tired of taking pills? Busy people love these 'hassle-free' vitamin patches that work while you go about your day
What if we told you that we found a way for you to get all your vitamins without a single pill? Well, that is exactly what we are here to tell you! There is a whole new way to wellness and it comes in the form of subtle stickers. PatchAid is the brand leading the future with innovative transdermal vitamins (aka vitamin absorption via the skin!). PatchAid Ditch the pills — not the vitamins. Make the switch to the wellness trend that has everyone talking with these innovative vitamin patches! Packed with essential ingredients, these patches absorb seamlessly into the blood. No matter what boost you are looking for PatchAid has your back. Shop PatchAid anywhere! You can wear your vitamins on an dry surface of skin without any marks left behind Typical vitamin supplements in a pill form have been around forever, but the downfalls of them are sneakier than you may have once thought. Ingestible pills can be hard to swallow, upsetting to the stomach, and lack of absorption in the digestive track. With logy, you can get your daily dose of vitamins simply from peeling and sticking (No, seriously!). The small adhesive patches are gentle on the skin and allergen-friendly, allowing users of all ages, even kids, to stock up on vitamins fuss-free. Using the PatchAid stick on wellness boosters truly is easy. All you have to do it find a clean, dry, and relatively hairless patch of skin then stick and enjoy eight hours of carefree nutrient absorption. Shoppers can not believe the difference, with one saying: 'The Multi Plus Topical Patch by PatchAid has become an essential part of my daily routine, offering a convenient and effective way to ensure I get the vitamins and minerals I need to stay healthy and energized. 'These patches provide a hassle-free alternative to traditional oral supplements, delivering essential nutrients directly through the skin for maximum absorption.'
